Katja Schuster

793 total citations
18 papers, 642 citations indexed

About

Katja Schuster is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Katja Schuster has authored 18 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Katja Schuster's work include Cancer-related Molecular Pathways (7 papers), RNA modifications and cancer (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Katja Schuster is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), RNA modifications and cancer (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Katja Schuster collaborates with scholars based in United States, Germany and Switzerland. Katja Schuster's co-authors include Pier Paolo Scaglioni, Adi F. Gazdar, Sofia Honorio, Jerry W. Shay, Jill E. Larsen, Monica Spinola, Michael Dodge, James P. Sullivan, Laura A. Sullivan and J. Michael DiMaio and has published in prestigious journals such as Blood, Cancer and Cancer Research.

In The Last Decade

Katja Schuster

18 papers receiving 635 citations

Peers

Katja Schuster
Roza Zandi Denmark
Thanh Von United States
Marc Payton United States
Leila Dardaei United States
Peter Čamaj Germany
Katja Schuster
Citations per year, relative to Katja Schuster Katja Schuster (= 1×) peers Rosanna Lacalamita

Countries citing papers authored by Katja Schuster

Since Specialization
Citations

This map shows the geographic impact of Katja Schuster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja Schuster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja Schuster more than expected).

Fields of papers citing papers by Katja Schuster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katja Schuster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja Schuster. The network helps show where Katja Schuster may publish in the future.

Co-authorship network of co-authors of Katja Schuster

This figure shows the co-authorship network connecting the top 25 collaborators of Katja Schuster. A scholar is included among the top collaborators of Katja Schuster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katja Schuster. Katja Schuster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Schuster, Katja, Niranjan Venkateswaran, Andrea Rabellino, et al.. (2014). Nullifying the CDKN2AB Locus Promotes Mutant K-ras Lung Tumorigenesis. Molecular Cancer Research. 12(6). 912–923. 31 indexed citations
3.
Rabellino, Andrea, et al.. (2013). The SUMO Ligase PIAS1 Promotes the Progression and Survival of Solid Tumors of Different Histopathological Origins. The FASEB Journal. 27(S1). 1 indexed citations
4.
Schuster, Katja, Junke Zheng, Arnaldo Arbini, Cheng Cheng Zhang, & Pier Paolo Scaglioni. (2011). Selective targeting of the mTORC1/2 protein kinase complexes leads to antileukemic effects in vitro and in vivo. Blood Cancer Journal. 1(9). e34–e34. 9 indexed citations
5.
Sullivan, James P., Monica Spinola, Michael Dodge, et al.. (2010). Aldehyde Dehydrogenase Activity Selects for Lung Adenocarcinoma Stem Cells Dependent on Notch Signaling. Cancer Research. 70(23). 9937–9948. 334 indexed citations
6.
Konstantinidou, Georgia, Erik A. Bey, Andrea Rabellino, et al.. (2009). Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Blockade Is an Effective Radiosensitizing Strategy for the Treatment of Non–Small Cell Lung Cancer Harboring K-RAS Mutations. Cancer Research. 69(19). 7644–7652. 124 indexed citations
7.
Volk, Erin L., Liying Fan, Katja Schuster, Jerold E. Rehg, & Linda C. Harris. (2009). The MDM2-A Splice Variant of MDM2 Alters Transformation In vitro and the Tumor Spectrum in Both Arf- and p53-Null Models of Tumorigenesis. Molecular Cancer Research. 7(6). 863–869. 15 indexed citations
8.
Puri, Poonam, Nathalie Carayol, Harikrishnan Balachandran, et al.. (2009). Activation of the p38 Map kinase pathway is essential for the antileukemic effects of dasatinib. Leukemia & lymphoma. 50(12). 2017–2029. 40 indexed citations
9.
Puri, Poonam, Nathalie Carayol, Harikrishnan Balachandran, et al.. (2009). Activation of the p38 Map kinase pathway is essential for the antileukemic effects of dasatinib. Leukemia & lymphoma. 1–13. 1 indexed citations
10.
Volk, Erin L., et al.. (2008). MDM2-A, a common Mdm2 splice variant, causes perinatal lethality, reduced longevity and enhanced senescence. Disease Models & Mechanisms. 2(1-2). 47–55. 18 indexed citations
11.
Schuster, Katja & Linda C. Harris. (2007). Selection for mutations in the cDNAs of transgenic mice upon expression of an embryonic lethal protein. Transgenic Research. 16(4). 527–530. 3 indexed citations
12.
Schuster, Katja, Liying Fan, & Linda C. Harris. (2007). MDM2 Splice Variants Predominantly Localize to the Nucleoplasm Mediated by a COOH-Terminal Nuclear Localization Signal. Molecular Cancer Research. 5(4). 403–412. 15 indexed citations
13.
Taylor, Alan C., Katja Schuster, Pamela McKenzie, & Linda C. Harris. (2006). Differential cooperation of oncogenes with p53 and Bax to induce apoptosis in rhabdomyosarcoma. Molecular Cancer. 5(1). 53–53. 7 indexed citations
14.
Täubert, Helge, Katja Schuster, Ulrich Brinck, et al.. (2004). Loss of heterozygosity at 12q14–15 often occurs in stage I soft tissue sarcomas and is associated with MDM2 amplification in tumors at various stages. Pathology - Research and Practice. 200(4). 259–259. 1 indexed citations
15.
Schmidt, Hannelore, Matthias Meinhardt, Andrea Lohse, et al.. (2004). Comparative evaluation of microsatellite marker, AP-PCR and CGH studies in primary renal cell carcinoma. International Journal of Molecular Medicine. 13(6). 835–42. 4 indexed citations
16.
Täubert, Helge, Frank Bartel, Matthias Kappler, et al.. (2003). Reduced expression of hMSH2 protein is correlated to poor survival for soft tissue sarcoma patients. Cancer. 97(9). 2273–2278. 16 indexed citations
17.
Christoffers, Jens & Katja Schuster. (2003). A novel L‐neopentylglycine derivative as auxiliary for copper‐catalyzed asymmetric Michael reactions. Chirality. 15(9). 777–782. 11 indexed citations
18.
Täubert, Helge, Katja Schuster, Ulrich Brinck, et al.. (2003). Loss of Heterozygosity at 12q14-15 Often Occurs in Stage I Soft Tissue Sarcomas and Is Associated with MDM2 Amplification in Tumors at Various Stages. Modern Pathology. 16(11). 1109–1116. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026